US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
SNDK
$1,704.16
▼-0.92%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
SNDK
$1,704.16
▼-0.92%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Corcept Therapeutics Incorporated - Common Stock
(NQ:
CORT
)
122.03
+5.80 (+4.99%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corcept Therapeutics Incorporated - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
March 06, 2026
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...
Via
TheNewswire.com
Topics
Lawsuit
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
March 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 06, 2026
From
Schall Law
Via
GlobeNewswire
CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026
March 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026
March 06, 2026
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...
Via
TheNewswire.com
Topics
Lawsuit
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your
March 05, 2026
From
Grabar Law Office
Via
GlobeNewswire
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline
March 05, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
March 04, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
Law Offices of Frank R. Cruz Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
March 04, 2026
From
Law Offices of Frank R. Cruz
Via
Business Wire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
March 03, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Integer Holdings Corp. (NYSE: ITGR); Kyndryl Holdings (NYSE: KD); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
March 03, 2026
From
Grabar Law Office
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT
March 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
March 03, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 03, 2026
From
Schall Law
Via
GlobeNewswire
Investors of Corcept Therapeutics, Inc. (CORT) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 21, 2026
March 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Investors of Corcept Therapeutics, Inc. (CORT) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 21, 2026
March 03, 2026
NEW YORK, NY - March 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...
Via
TheNewswire.com
Topics
Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT)
March 03, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox
March 02, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox
March 02, 2026
NEW YORK, NY - March 2, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...
Via
TheNewswire.com
Topics
Lawsuit
Deadline Approaching: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
March 02, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Five9, Inc. (NASDAQ: FIVN); Integer Holdings Corp. (NYSE: ITGR); and Kyndryl Holdings (NYSE: KD): Grabar Law Office Investigates Claims on Your Behalf
March 02, 2026
From
Grabar Law Office
Via
GlobeNewswire
Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026
March 01, 2026
NEW YORK, NY - March 1, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...
Via
TheNewswire.com
Topics
Lawsuit
Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026
March 01, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox
February 28, 2026
NEW YORK, NY - February 28, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”)...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox
February 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
February 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
February 27, 2026
NEW YORK, NY - February 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”)...
Via
TheNewswire.com
Topics
Lawsuit
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
February 26, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
February 26, 2026
NEW YORK, NY - February 26, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”)...
Via
TheNewswire.com
Topics
Lawsuit
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
February 26, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
